Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer
Shunsuke Sakuraba(Juntendo University Shizuoka Hospital), Kazunori Kato(Toyo University)
Cited by 2
Related Papers
Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)
|European Journal of Nuclear Medicine and Molecular Imaging|2025|6
Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy
|International Journal of Molecular Sciences|2025|1